Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
07/2007
07/18/2007CN1326518C Peripateticism soft capsule and its preparation technology
07/18/2007CN1326467C Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes
07/18/2007CN101001880A Method of treating granuloma annulare or sarcoid
07/18/2007CN101001859A Pyrrolopyridine derivatives
07/18/2007CN101001857A 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones
07/18/2007CN101001847A 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
07/18/2007CN101001843A Nicotinic receptor agonists for the treatment of inflammatory diseases
07/18/2007CN101001645A Il-17 antagonistic antibodies
07/18/2007CN101001630A Combination of selective noradrenalin reabsorption inhibitor and PDEV inhibitor
07/18/2007CN101001626A Pyrazole derivatives for treating conditions mediated by activation of the adenosine A2b or A3 receptor
07/18/2007CN100998870A Stable polymer micelle medicine carrging system
07/18/2007CN100998864A Cyclosporin A semisolid skeleton capsule and its preparation method
07/18/2007CN100998853A Chinese medicine for treating articular disease and its preparation method
07/18/2007CN100998838A Chinese medicine for relaxing muscles and tendons to promote blood circulation preparation method thereof
07/18/2007CN100998837A Black adhesive plaster for removing obstruction and relieving pain
07/18/2007CN100998827A Decoction for treating waist sprain and its preparation method
07/18/2007CN100998826A Decoction medicine for treating omitis and its preparation method
07/18/2007CN100998801A Oral administration Chinese medicine for treating summer heat type cold
07/18/2007CN100998746A Oral traditional Chinese medicine for treating feverish type acute bronchitis
07/18/2007CN100998741A Traditional Chinese medicine composition for treating pains of articulus and soft tissue, and plaster thereof and its preparing method
07/18/2007CN100998740A Atoxic traditional Chinese medicine composition for treating rheumatosis and rheumatoid disease
07/18/2007CN100998709A Plaster for treating pains on neck, shoulder, lumbar and legs
07/18/2007CN100998707A Medical herbs of decoction for treating sciatica and its preparing method
07/18/2007CN100998706A Medical herbs of decoction for treating lumbar muscle degeneration and its preparing method
07/18/2007CN100998700A Oral traditional Chinese medicine for treating influenza
07/18/2007CN100998680A Ointment for treating bone diseases and its preparing method
07/18/2007CN100998660A Traditional Chinese medicine plaster for treating vertebral artery type cervical spondylosis and its preparing method
07/18/2007CN100998646A Method for processing Chinese herb medicine-red rooted salvia
07/18/2007CN100998631A Medicine form of low toxin thunder godvine extract by using new processing method
07/18/2007CN100998630A Plaster for treating hyperosteogeny, neuro-pain and various kinds of inflammation
07/18/2007CN100998629A Traditional Chinese medicine for treating thermo-toxin type cold
07/18/2007CN100998607A Injecta containing compound bone peptide and sodium chloride
07/18/2007CN100998583A Novel use of Bitai-en for protecting liver stem cell, eliminating apoptosis of said cells and protecting nepatic function
07/17/2007US7244849 Reaction of a phenoxypropionic acid compound with a trifluoromethylphenylthiazole compound; for manufacture of a medicament for treatment of a human peroxisome proliferator activated receptor alpha mediated disease or condition such as hypercholesteremia, cardiovascular disease
07/17/2007US7244846 Substituted benzofuran-2-carboxamides derivatives
07/17/2007US7244767 Therapy for multiple sclerosis, psoriasis, urticaria; antiarthritic agents; incotinence; antitumor, anticancer agents
07/17/2007US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
07/17/2007US7244746 Imidazolyl derivatives as corticotropin releasing factor inhibitors
07/17/2007US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy
07/17/2007US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
07/17/2007US7244412 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
07/17/2007CA2388639C Inhibitors of .alpha.l.beta.2 mediated cell adhesion
07/17/2007CA2373944C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
07/17/2007CA2298445C Method and compositions for treating late phase allergic reactions and inflammatory diseases
07/17/2007CA2182013C Humanized antibodies against leukocyte adhesion molecule vla-4
07/17/2007CA2172506C Mycophenolate mofetil and mycophenolic acid high dose oral suspensions
07/17/2007CA2160161C Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors
07/17/2007CA2158610C 17-deoxycorticosteroid-21-/o/-carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds
07/12/2007WO2007079078A1 Diamine derivatives as inhibitors of leukotriene a4 hydrolase
07/12/2007WO2007078874A2 Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
07/12/2007WO2007078335A2 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
07/12/2007WO2007077990A1 Drug delivery material
07/12/2007WO2007077934A1 Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same
07/12/2007WO2007077861A1 NF-κB INHIBITOR
07/12/2007WO2007061739A3 Pharmaceutical compositions comprising buprenorphine
07/12/2007WO2007056091A3 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof
07/12/2007WO2007054279A8 Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions
07/12/2007WO2007038314A3 Fused heterocyclic compounds useful as kinase modulators
07/12/2007WO2007038209A3 Fused tetracyclic mglur1 antagonists as therapeutic agents
07/12/2007WO2007034279A3 C3a antagonists and pharmaceutical compositions thereof
07/12/2007WO2007006041A8 Imaging and therapeutic method using monocytes
07/12/2007WO2003077723A3 Methods and devices for detection and therapy of atheromatous plaque
07/12/2007US20070161707 Pharmaceutical uses for alpha2delta ligands
07/12/2007US20070161706 Pharmaceutical uses for alpha2delta ligands
07/12/2007US20070161684 3-Aminocarbonyl, 6-phenyl substituted pyridine-1-oxides as p38 kinase inhibitors
07/12/2007US20070161681 Ether derivatives useful as inhibitors of pde4 isozymes
07/12/2007US20070161666 Pyrrolo[2,3-d]pyrimidine compounds
07/12/2007US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS
07/12/2007US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5)
07/12/2007US20070161635 Kinase inhibitors
07/12/2007US20070161633 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
07/12/2007US20070161614 Pyridylether derivatives, their preparation and use
07/12/2007US20070161597 A time-release formulation of a water-soluble derivative having the fatty acid moiety removed and an antiinflammatory agent; opoid resistant neuropathic pain, amputation pain or neuralgia;
07/12/2007US20070161560 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain
07/12/2007US20070161046 Truncated aggrecanase molecules
07/12/2007US20070160668 Prolonged release bioadhesive therapeutic systems
07/12/2007US20070160603 Antibodies Against Tumor Necrosis Factor Delta (APRIL)
07/12/2007US20070160600 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
07/12/2007US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders
07/12/2007US20070160575 Anth1 chimeric antagonist
07/12/2007US20070160570 Chimeric polypeptides containing chemokine domains
07/12/2007US20070160545 Method for reducing ultraviolet light induced apoptosis
07/12/2007CA2636929A1 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
07/12/2007CA2635849A1 An antibody against periosin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periosin is involved
07/11/2007EP1806338A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxy­phenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same
07/11/2007EP1806147A1 Use of immunesuppressant receptor
07/11/2007EP1806146A1 Agonists or antagonists of cutaneous T cell-attracting chemokine (CTACK) or vasoactive intestinal contractor (VIC) chemokines
07/11/2007EP1806145A1 Remedy for inflammatory diseases
07/11/2007EP1806144A2 Use of SARP-1 for the treatment and/or prevention of scleroderma
07/11/2007EP1806143A2 Baff receptor (BCMA), an immunoregulatory agent
07/11/2007EP1805210A1 Novel peptides and methods for the treatment of inflammatory disease
07/11/2007EP1805202A2 Conjugates with anti-inflammatory activity
07/11/2007EP1805181A1 Purine derivatives for use as adenosin a-2a receptor agonists
07/11/2007EP1805170A1 Mif-inhibitors
07/11/2007EP1805165A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists
07/11/2007EP1805154A2 Pharmaceutical compositions
07/11/2007EP1805139A2 Therapeutic and delivery methods of prostaglandin ep4 agonists
07/11/2007EP1804838A2 Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs
07/11/2007EP1804828A2 The use of a protease or a protease inhibitor for the manufacture of medicaments
07/11/2007EP1804813A2 Formulations and methods for treatment of inflammatory diseases